Comparative transcriptional study of the effects of high intracellular zinc on prostate carcinoma cells

Oncology Reports

Volumn 23, Issue 6, 2010, Pages 1501-1516

  Wong, Pooi Fong ^a   Abubakar, Sazaly ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Gene superinduction; Microarray; Trace element; Tumorigenesis

Indexed keywords

CD164 ANTIGEN; FIBRILLARIN; PROSTATE ANTIGEN; SIX TRANSMEMBRANE EPITHELIAL ANTIGEN OF THE PROSTATE 1; UNCLASSIFIED DRUG; ZINC; MESSENGER RNA; TRACE ELEMENT; TUMOR MARKER;

ARTICLE; CANCER CELL; CELL GROWTH; CELL LEVEL; CELL PROLIFERATION; COLONY FORMATION; COMPARATIVE STUDY; CONTROLLED STUDY; CULTURE MEDIUM; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CARCINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNINDEXED SEQUENCE; CFU COUNTING; DNA MICROARRAY; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; PROSTATIC NEOPLASMS; TUMOR CELL CULTURE;

CELL PROLIFERATION; COLONY-FORMING UNITS ASSAY; GENE EXPRESSION PROFILING; HUMANS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRACE ELEMENTS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; ZINC;

EID: 77951751924     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000789     Document Type: Article

References (84)

1. Vasto S, Candore G, Listi F, Balistreri CR, Colonna-Romano G, Malavolta M, Lio D, Nuzzo D, Mocchegiani E, Di Bona D and Caruso C: Inflammation, genes and zinc in Alzheimer's disease. Brain Res Rev 58: 96-105, 2008.
2. Devirgiliis C, Zalewski PD, Perozzi G and Murgia C: Zinc fluxes and zinc transporter genes in chronic diseases. Mutat Res 622: 84-93, 2007.
3. Donadelli M, Dalla Pozza E, Costanzo C, Scupoli MT, Scarpa A and Palmieri M: Zinc depletion efficiently inhibits pancreatic cancer cell growth by increasing the ratio of antiproliferative/proliferative genes. J Cell Biochem 104: 202-212, 2008.
4. Costello LC, Feng P, Milon B, Tan M and Franklin RB: Role of zinc in the pathogenesis and treatment of prostate cancer: critical issues to resolve. Prostate Cancer Prostatic Dis 7: 111-117, 2004.
5. Kumar A, Chatopadhyay T, Raziuddin M and Ralhan R: Discovery of deregulation of zinc homeostasis and its associated genes in esophageal squamous cell carcinoma using cDNA microarray. Int J Cancer 120: 230-242, 2007.
6. Blanchard RK, Moore JB, Green CL and Cousins RJ: Modulation of intestinal gene expression by dietary zinc status: effectiveness of cDNA arrays for expression profiling of a single nutrient deficiency. Proc Natl Acad Sci USA 98: 13507-13513, 2001.
7. Sun JY, Wang JF, Zi NT, Jing MY and Weng XY: Gene expression profiles analysis of the growing rat liver in response to different zinc status by cDNA microarray analysis. Biol Trace Elem Res 115: 169-185, 2007.
8. Tom Dieck H, Doring F, Roth HP and Daniel H: Changes in rat hepatic gene expression in response to zinc deficiency as assessed by DNA arrays. J Nutr 133: 1004-1010, 2003.
9. Haase H, Mazzatti DJ, White A, Ibs KH, Engelhardt G, Hebel S, Powell JR and Rink L: Differential gene expression after zinc supplementation and deprivation in human leukocyte subsets. Mol Med 13: 362-370, 2007.
10. Aydemir TB, Blanchard RK and Cousins RJ: Zinc supplementation of young men alters metallothionein, zinc transporter, and cytokine gene expression in leukocyte populations. Proc Natl Acad Sci USA 103: 1699-1704, 2006.
11. Cousins RJ, Blanchard RK, Popp MP, Liu L, Cao J, Moore JB and Green CL: A global view of the selectivity of zinc deprivation and excess on genes expressed in human THP-1 mononuclear cells. Proc Natl Acad Sci USA 100: 6952-6957, 2003.
12. Andree KB, Kim J, Kirschke CP, Gregg JP, Paik H, Joung H, Woodhouse L, King JC and Huang L: Investigation of lymphocyte gene expression for use as biomarkers for zinc status in humans. J Nutr 134: 1716-1723, 2004.
13. Beck FW, Li Y, Bao B, Prasad AS and Sarkar FH: Evidence for reprogramming global gene expression during zinc deficiency in the HUT-78 cell line. Nutrition 22: 1045-1056, 2006.
14. Kindermann B, Doring F, Pfaffl M and Daniel H: Identification of genes responsive to intracellular zinc depletion in the human colon adenocarcinoma cell line HT-29. J Nutr 134: 57-62, 2004.
15. Yan M, Song Y, Wong CP, Hardin K and Ho E: Zinc deficiency alters DNA damage response genes in normal human prostate epithelial cells. J Nutr 138: 667-673, 2008.
16. Ebisch IM, Thomas CM, Peters WH, Braat DD and Steegers-Theunissen RP: The importance of folate, zinc and antioxidants in the pathogenesis and prevention of subfertility. Hum Reprod Update 13: 163-174, 2007.
17. Zaichick V, Sviridova TV and Zaichick SV: Zinc in the human prostate gland: normal, hyperplastic and cancerous. Int Urol Nephrol 29: 565-574, 1997. (Pubitemid 27489811)
18. Uzzo RG, Crispen PL, Golovine K, Makhov P, Horwitz EM and Kolenko VM: Diverse effects of zinc on NF-kappaB and AP-1 transcription factors: implications for prostate cancer progression. Carcinogenesis 27: 1980-1990, 2006.
19. Gioeli D: Signal transduction in prostate cancer progression. Clin Sci (London) 108: 293-308, 2005.
20. Feng P, Li TL, Guan ZX, Franklin RB and Costello LC: Direct effect of zinc on mitochondrial apoptogenesis in prostate cells. Prostate 52: 311-318, 2002.
21. Ishii K, Usui S, Sugimura Y, Yamamoto H, Yoshikawa K and Hirano K: Inhibition of aminopeptidase N (AP-N) and urokinase-type plasminogen activator (uPA) by zinc suppresses the invasion activity in human urological cancer cells. Biol Pharm Bull 24: 226-230, 2001. (Pubitemid 32237158)
22. Boissier S, Ferreras M, Peyruchaud O, Magnetto S, Ebetino FH, Colombel M, Delmas P, Delaisse JM and Clezardin P: Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases. Cancer Res 60: 2949-2954, 2000.
23. 2+ ions modulate the VHR, ZAP-70 and ERK activities of LNCaP prostate cancer cells. Cell Mol Biol Lett 13: 375-390, 2008.
24. Wong PF and Abubakar S: LNCaP prostate cancer cells are insensitive to zinc-induced senescence. J Trace Elem Med Biol 22: 242-247, 2008.
25. Benjamini Y and Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B (Methodological) 57: 289-300, 1995.
26. Beisvag V, Junge FK, Bergum H, Jolsum L, Lydersen S, Gunther CC, Ramampiaro H, Langaas M, Sandvik AK and Laegreid A: GeneTools- application for functional annotation and statistical hypothesis testing. BMC Bioinformatics 7: 470, 2006.
27. Huggett J, Dheda K, Bustin S and Zumla A: Real-time RTPCR normalisation, strategies and considerations. Genes Immun 6: 279-284, 2005.
28. Rouault JP, Falette N, Guehenneux F, Guillot C, Rimokh R, Wang Q, Berthet C, Moyret-Lalle C, Savatier P, Pain B, Shaw P, Berger R, Samarut J, Magaud JP, Ozturk M, Samarut C and Puisieux A: Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat Genet 14: 482-486, 1996.
29. Ohtsuka T, Ryu H, Minamishima YA, Ryo A and Lee SW: Modulation of p53 and p73 levels by cyclin G: implication of a negative feedback regulation. Oncogene 22: 1678-1687, 2003.
30. Machida T, Fujita T, Ooo ML, Ohira M, Isogai E, Mihara M, Hirato J, Tomotsune D, Hirata T, Fujimori M, Adachi W and Nakagawara A: Increased expression of proapoptotic BMCC1, a novel gene with the BNIP2 and Cdc42GAP homology (BCH) domain, is associated with favorable prognosis in human neuroblastomas. Oncogene 25: 1931-1942, 2006.
31. Meenakshi J, Anupama, Goswami SK and Datta K: Constitutive expression of hyaluronan binding protein 1 (HABP1/p32/ gC1qR) in normal fibroblast cells perturbs its growth characteristics and induces apoptosis. Biochem Biophys Res Commun 300: 686-693, 2003.
32. Lee YH, Lee JC, Moon HJ, Jung JE, Sharma M, Park BH, Yi HK and Jhee EC: Differential effect of oxidative stress on the apoptosis of early and late passage human diploid fibroblasts: implication of heat shock protein 60. Cell Biochem Funct 26: 502-508, 2008.
33. Budanov AV, Shoshani T, Faerman A, Zelin E, Kamer I, Kalinski H, Gorodin S, Fishman A, Chajut A, Einat P, Skaliter R, Gudkov AV, Chumakov PM and Feinstein E: Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability. Oncogene 21: 6017-6031, 2002.
34. Ramsden JJ: MARCKS: a case of molecular exaptation? Int J Biochem Cell Biol 32: 475-479, 2000.
35. Martinez-Arribas F, Agudo D, Pollan M, Gomez-Esquer F, Diaz-Gil G, Lucas R and Schneider J: Positive correlation between the expression of X-chromosome RBM genes (RBMX, RBM3, RBM10) and the proapoptotic Bax gene in human breast cancer. J Cell Biochem 97: 1275-1282, 2006.
36. Jin R, Huang J, Tan PH and Bay BH: Clinicopathological significance of metallothioneins in breast cancer. Pathol Oncol Res 10: 74-79, 2004.
37. Tiberi L, Faisal A, Rossi M, Di Tella L, Franceschi C and Salvioli S: p66(Shc) gene has a pro-apoptotic role in human cell lines and it is activated by a p53-independent pathway. Biochem Biophys Res Commun 342: 503-508, 2006.
38. Iwanaga R, Komori H and Ohtani K: Differential regulation of expression of the mammalian DNA repair genes by growth stimulation. Oncogene 23: 8581-8590, 2004.
39. Kanu N and Behrens A: ATMINistrating ATM signalling: regulation of ATM by ATMIN. Cell Cycle 7: 3483-3486, 2008.
40. Bladen CL, Udayakumar D, Takeda Y and Dynan WS: Identification of the polypyrimidine tract binding protein-associated splicing factor.p54(nrb) complex as a candidate DNA double-strand break rejoining factor. J Biol Chem 280: 5205-5210, 2005.
41. Singh R, Lemire J, Mailloux RJ and Appanna VD: A novel strategy involved anti-oxidative defense: the conversion of NADH into NADPH by a metabolic network. PLoS One 3: e2682, 2008.
42. Lu DD, Chen YC, Zhang XR, Cao XR, Jiang HY and Yao L: The relationship between metallothionein-1F (MT1F) gene and hepatocellular carcinoma. Yale J Biol Med 76: 55-62, 2003.
43. Hellborg F, Qian W, Mendez-Vidal C, Asker C, Kost-Alimova M, Wilhelm M, Imreh S and Wiman KG: Human wig-1, a p53 target gene that encodes a growth inhibitory zinc finger protein. Oncogene 20: 5466-5474, 2001.
44. Havens AM, Jung Y, Sun YX, Wang J, Shah RB, Buhring HJ, Pienta KJ and Taichman RS: The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis. BMC Cancer 6: 195, 2006.
45. Rossi S, Graner E, Febbo P, Weinstein L, Bhattacharya N, Onody T, Bubley G, Balk S and Loda M: Fatty acid synthase expression defines distinct molecular signatures in prostate cancer. Mol Cancer Res 1: 707-715, 2003.
46. Moore S, Knudsen B, True LD, Hawley S, Etzioni R, Wade C, Gifford D, Coleman I and Nelson PS: Loss of stearoyl-CoA desaturase expression is a frequent event in prostate carcinoma. Int J Cancer 114: 563-571, 2005.
47. Ishiguro H, Uemura H, Fujinami K, Ikeda N, Ohta S and Kubota Y: 55 kDa nuclear matrix protein (nmt55) mRNA is expressed in human prostate cancer tissue and is associated with the androgen receptor. Int J Cancer 105: 26-32, 2003.
48. Bogni A, Cheng C, Liu W, Yang W, Pfeffer J, Mukatira S, French D, Downing JR, Pui CH and Relling MV: Genome-wide approach to identify risk factors for therapy-related myeloid leukemia. Leukemia 20: 239-246, 2006.
49. Went P, Vasei M, Bubendorf L, Terracciano L, Tornillo L, Riede U, Kononen J, Simon R, Sauter G and Baeuerle PA: Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. Br J Cancer 94: 128-135, 2006.
50. Lapointe J, Li C, Higgins JP, van de Rijn M, Bair E, Montgomery K, Ferrari M, Egevad L, Rayford W, Bergerheim U, Ekman P, DeMarzo AM, Tibshirani R, Botstein D, Brown PO, Brooks JD and Pollack JR: Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci USA 101: 811-816, 2004.
51. Rasheed S, Harris AL, Tekkis PP, Turley H, Silver A, McDonald PJ, Talbot IC, Glynne-Jones R, Northover JM and Guenther T: Hypoxia-inducible factor-1alpha and -2alpha are expressed in most rectal cancers but only hypoxia-inducible factor-1alpha is associated with prognosis. Br J Cancer 100: 1666-1673, 2009.
52. Mollaoglu N, Vairaktaris E, Nkenke E, Neukam FW and Ries J: Expression of MAGE-A12 in oral squamous cell carcinoma. Dis Markers 24: 27-32, 2008.
53. Vaarala MH, Porvari KS, Kyllonen AP, Mustonen MV, Lukkarinen O and Vihko PT: Several genes encoding ribosomal proteins are over-expressed in prostate-cancer cell lines: confirmation of L7a and L37 over-expression in prostate-cancer tissue samples. Int J Cancer 78: 27-32, 1998.
54. Bai L and Merchant JL: A role for CITED2, a CBP/p300 interacting protein, in colon cancer cell invasion. FEBS Lett 581: 5904-5910, 2007.
55. He H, Dai F, Yu L, She X, Zhao Y, Jiang J, Chen X and Zhao S: Identification and characterization of nine novel human small GTPases showing variable expressions in liver cancer tissues. Gene Expr 10: 231-242, 2002.
56. Choi YW, Kim YW, Bae SM, Kwak SY, Chun HJ, Tong SY, Lee HN, Shin JC, Kim KT, Kim YJ and Ahn WS: Identification of differentially expressed genes using annealing control primer-based GeneFishing in human squamous cell cervical carcinoma. Clin Oncol (R Coll Radiol) 19: 308-318, 2007.
57. Suzuki S, Takahashi S, Takeshita K, Hikosaka A, Wakita T, Nishiyama N, Fujita T, Okamura T and Shirai T: Expression of prothymosin alpha is correlated with development and progression in human prostate cancers. Prostate 66: 463-469, 2006.
58. Rizzi F, Belloni L, Crafa P, Lazzaretti M, Remondini D, Ferretti S, Cortellini P, Corti A and Bettuzzi S: A novel gene signature for molecular diagnosis of human prostate cancer by RT-qPCR. PLoS One 3: e3617, 2008.
59. Dunn TA, Chen S, Faith DA, Hicks JL, Platz EA, Chen Y, Ewing CM, Sauvageot J, Isaacs WB, De Marzo AM and Luo J: A novel role of myosin VI in human prostate cancer. Am J Pathol 169: 1843-1854, 2006.
60. Aerts JL, Gonzales MI and Topalian SL: Selection of appropriate control genes to assess expression of tumor antigens using real-time RT-PCR. Biotechniques 36: 84-91, 2004.
61. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A and Speleman F: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: Research0034, 2002.
62. Albrecht AL, Somji S, Sens MA, Sens DA and Garrett SH: Zinc transporter mRNA expression in the RWPE-1 human prostate epithelial cell line. Biometals 21: 405-416, 2008.
63. Feng P, Liang JY, Li TL, Guan ZX, Zou J, Franklin R and Costello LC: Zinc induces mitochondria apoptogenesis in prostate cells. Mol Urol 4: 31-36, 2000.
64. 2+ axis may play a role in human prostate cancer cell invasion. Cancer Lett 207: 79-87, 2004.
65. Nemoto K, Kondo Y, Himeno S, Suzuki Y, Hara S, Akimoto M and Imura N: Modulation of telomerase activity by zinc in human prostatic and renal cancer cells. Biochem Pharmacol 59: 401-405, 2000.
66. Ho E: Zinc deficiency, DNA damage and cancer risk. J Nutr Biochem 15: 572-578, 2004.
67. Franklin RB and Costello LC: Zinc as an anti-tumor agent in prostate cancer and in other cancers. Arch Biochem Biophys 463: 211-217, 2007.
68. Gallus S, Foschi R, Negri E, Talamini R, Franceschi S, Montella M, Ramazzotti V, Tavani A, Dal Maso L and La Vecchia C: Dietary zinc and prostate cancer risk: a case-control study from Italy. Eur Urol 52: 1052-1056, 2007.
69. Lawson KA, Wright ME, Subar A, Mouw T, Hollenbeck A, Schatzkin A and Leitzmann MF: Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study. J Natl Cancer Inst 99: 754-764, 2007. (Pubitemid 47073522)
70. Leitzmann MF, Stampfer MJ, Wu K, Colditz GA, Willett WC and Giovannucci EL: Zinc supplement use and risk of prostate cancer. J Natl Cancer Inst 95: 1004-1007, 2003.
71. Lagiou P, Wuu J, Trichopoulou A, Hsieh CC, Adami HO and Trichopoulos D: Diet and benign prostatic hyperplasia: a study in Greece. Urology 54: 284-290, 1999. (Pubitemid 29367253)
72. Moyad MA: Zinc for prostate disease and other conditions: a little evidence, a lot of hype, and a significant potential problem. Urol Nurs 24: 49-52, 2004.
73. Zannettino AC, Buhring HJ, Niutta S, Watt SM, Benton MA and Simmons PJ: The sialomucin CD164 (MGC-24v) is an adhesive glycoprotein expressed by human hematopoietic progenitors and bone marrow stromal cells that serves as a potent negative regulator of hematopoiesis. Blood 92: 2613-2628, 1998.
74. Trzpis M, McLaughlin PM, de Leij LM and Harmsen MC: Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule. Am J Pathol 171: 386-395, 2007.
75. Amin MA, Matsunaga S, Ma N, Takata H, Yokoyama M, Uchiyama S and Fukui K: Fibrillarin, a nucleolar protein, is required for normal nuclear morphology and cellular growth in HeLa cells. Biochem Biophys Res Commun 360: 320-326, 2007.
76. Zhang JY, Wang X, Peng XX and Chan EK: Autoantibody responses in Chinese hepatocellular carcinoma. J Clin Immunol 22: 98-105, 2002.
77. Hubert RS, Vivanco I, Chen E, Rastegar S, Leong K, Mitchell SC, Madraswala R, Zhou Y, Kuo J, Raitano AB, Jakobovits A, Saffran DC and Afar DE: STEAP: a prostate-specific cell-surface antigen highly expressed in human prostate tumors. Proc Natl Acad Sci USA 96: 14523-14528, 1999.
78. Ohgami RS, Campagna DR, McDonald A and Fleming MD: The Steap proteins are metalloreductases. Blood 108: 1388-1394, 2006.
79. Berg JM and Shi Y: The galvanization of biology: a growing appreciation for the roles of zinc. Science 271: 1081-1085, 1996.
80. Arany I, Faisal A, Nagamine Y and Safirstein RL: p66shc inhibits pro-survival epidermal growth factor receptor/ERK signaling during severe oxidative stress in mouse renal proximal tubule cells. J Biol Chem 283: 6110-6117, 2008.
81. Hanlon PR, Ganem LG, Cho YC, Yamamoto M and Jefcoate CR: AhR- and ERK-dependent pathways function synergistically to mediate 2,3,7,8- tetrachlorodibenzo-p-dioxin suppression of peroxisome proliferator-activated receptor-gamma1 expression and subsequent adipocyte differentiation. Toxicol Appl Pharmacol 189: 11-27, 2003.
82. Kim SW, Hayashi M, Lo JF, Yang Y, Yoo JS and Lee JD: ADP-ribosylation factor 4 small GTPase mediates epidermal growth factor receptor-dependent phospholipase D2 activation. J Biol Chem 278: 2661-2668, 2003.
83. Casas-Terradellas E, Tato I, Bartrons R, Ventura F and Rosa JL: ERK and p38 pathways regulate amino acid signalling. Biochim Biophys Acta 1783: 2241-2254, 2008.
84. Hotta K, Tanaka K, Mino A, Kohno H and Takai Y: Interaction of the Rho family small G proteins with kinectin, an anchoring protein of kinesin motor. Biochem Biophys Res Commun 225: 69-74, 1996.